Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 12, 2024
Abstract
The
2002
SARS
outbreak,
the
2019
emergence
of
COVID-19,
and
continuing
evolution
immune-evading
SARS-CoV-2
variants
together
highlight
need
for
a
broadly
protective
vaccine
against
ACE2-utilizing
sarbecoviruses.
While
updated
variant-matched
formulations
are
step
in
right
direction,
protection
needs
to
extend
beyond
its
include
SARS-like
viruses.
Here,
we
introduce
bivalent
trivalent
using
our
spike
protein
nanoparticle
platform
that
completely
protect
female
hamsters
BA.5
XBB.1
challenges
with
no
detectable
virus
lungs.
cocktails
elicit
highly
neutralizing
responses
all
tested
Omicron
bat
sarbecoviruses
SHC014
WIV1.
Finally,
614D/SHC014/XBB
formulation
protects
human
ACE2-transgenic
WIV1
Collectively,
these
results
illustrate
protein-nanoparticle
cocktail
can
provide
broad
SARS-CoV-2-like
SARS-CoV-1-like
Science,
Journal Year:
2022,
Volume and Issue:
377(6609), P. 960 - 966
Published: July 26, 2022
Understanding
the
circumstances
that
lead
to
pandemics
is
important
for
their
prevention.
We
analyzed
genomic
diversity
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
early
in
disease
2019
(COVID-19)
pandemic.
show
SARS-CoV-2
before
February
2020
likely
comprised
only
two
distinct
viral
lineages,
denoted
"A"
and
"B."
Phylodynamic
rooting
methods,
coupled
with
epidemic
simulations,
reveal
these
lineages
were
result
at
least
separate
cross-species
transmission
events
into
humans.
The
first
zoonotic
involved
lineage
B
viruses
around
18
November
(23
October
8
December),
introduction
A
occurred
within
weeks
this
event.
These
findings
indicate
it
unlikely
circulated
widely
humans
define
narrow
window
between
when
jumped
cases
COVID-19
reported.
As
other
coronaviruses,
emergence
resulted
from
multiple
events.
Cold Spring Harbor Perspectives in Medicine,
Journal Year:
2022,
Volume and Issue:
12(5), P. a041390 - a041390
Published: April 20, 2022
Our
understanding
of
the
still
unfolding
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
would
have
been
extremely
limited
without
study
genetics
and
evolution
this
new
human
coronavirus.
Large-scale
genome-sequencing
efforts
provided
close
to
real-time
tracking
global
spread
diversification
SARS-CoV-2
since
its
entry
into
population
in
late
2019.
These
data
underpinned
analysis
origins,
epidemiology,
adaptations
population:
principally
immune
evasion
increasing
transmissibility.
SARS-CoV-2,
despite
being
a
pathogen,
was
highly
capable
human-to-human
transmission.
During
rapid
humans,
has
evolved
independent
forms,
so-called
"variants
concern,"
that
are
better
optimized
for
The
most
important
adaptation
bat
progenitor
both
SARS-CoV-1
infection
(and
other
mammals)
is
use
angiotensin-converting
enzyme
(ACE2)
receptor.
Relaxed
structural
constraints
provide
plasticity
SARS-related
spike
protein
permitting
it
accommodate
significant
amino
acid
replacements
antigenic
consequence
compromising
ability
bind
ACE2.
Although
bulk
research
justifiably
concentrated
on
viral
as
main
determinant
changes
transmissibility,
there
accumulating
evidence
contribution
regions
proteome
virus-host
interaction.
Whereas
levels
community
transmission
recombinants
genetically
distinct
variants
at
present
low,
when
divergent
cocirculate,
recombination
between
clades
detected,
risk
viruses
with
properties
emerge.
Applying
computational
machine
learning
methods
genome
sequence
sets
generate
experimentally
verifiable
predictions
will
serve
an
early
warning
system
novel
variant
surveillance
be
future
vaccine
planning.
Omicron,
latest
concern,
focused
attention
step
change
events,
"shift,"
opposed
incremental
"drift"
antigenicity.
Both
increase
transmissibility
shift
Omicron
led
readily
causing
infections
fully
vaccinated
and/or
previously
infected.
Omicron's
virulence,
while
reduced
relative
concern
replaced,
Delta,
very
much
premised
past
exposure
individuals
clear
signal
boosted
vaccination
protects
from
disease.
Currently,
proven
itself
dangerous
pathogen
unpredictable
evolutionary
capacity,
leading
too
great
not
ensure
all
world
screened
by
sequencing,
protected
through
available
affordable
vaccines,
non-punitive
strategies
place
detecting
responding
concern.
Genome Biology and Evolution,
Journal Year:
2022,
Volume and Issue:
14(2)
Published: Feb. 1, 2022
Abstract
The
lack
of
an
identifiable
intermediate
host
species
for
the
proximal
animal
ancestor
SARS-CoV-2,
and
large
geographical
distance
between
Wuhan
where
closest
evolutionary
related
coronaviruses
circulating
in
horseshoe
bats
(members
Sarbecovirus
subgenus)
have
been
identified,
is
fueling
speculation
on
natural
origins
SARS-CoV-2.
We
performed
a
comprehensive
phylogenetic
study
SARS-CoV-2
all
bat
pangolin
sarbecoviruses
sampled
so
far.
Determining
likely
recombination
events
reveals
highly
reticulate
history
within
this
group
coronaviruses.
Distribution
inferred
nonrandom
with
evidence
that
Spike,
main
target
humoral
immunity,
beside
hotspot
driving
antigenic
shift
ancestry
sarbecoviruses.
Coupled
geographic
ranges
their
hosts
sampling
locations,
across
southern
China,
into
Southeast
Asia,
we
confirm
bats,
Rhinolophus,
are
reservoir
progenitor.
By
tracing
recombinant
sequence
patterns,
conclude
there
has
relatively
recent
movement
cocirculation
these
viruses’
ancestors,
extending
China
Asia
over
last
100
years.
direct
to
not
yet
sampled,
since
known
relatives
collected
Yunnan
shared
common
approximately
40
years
ago.
Our
analysis
highlights
need
dramatically
more
wildlife
to:
1)
pinpoint
exact
SARS-CoV-2’s
progenitor,
2)
facilitated
transmission
from
humans
(if
one),
3)
survey
extent
diversity
sarbecoviruses’
phylogeny
present
high
risk
future
spillovers.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: July 10, 2023
Abstract
Bats
are
reservoir
hosts
for
many
zoonotic
viruses.
Despite
this,
relatively
little
is
known
about
the
diversity
and
abundance
of
viruses
within
individual
bats,
hence
frequency
virus
co-infection
spillover
among
them.
We
characterize
mammal-associated
in
149
bats
sampled
from
Yunnan
province,
China,
using
an
unbiased
meta-transcriptomics
approach.
This
reveals
a
high
(simultaneous
infection
bat
individuals
by
multiple
viral
species)
animals
studied,
which
may
turn
facilitate
recombination
reassortment.
Of
note,
we
identify
five
species
that
likely
to
be
pathogenic
humans
or
livestock,
based
on
phylogenetic
relatedness
pathogens
vitro
receptor
binding
assays.
includes
novel
recombinant
SARS-like
coronavirus
closely
related
both
SARS-CoV
SARS-CoV-2.
In
assays
indicate
this
can
utilize
human
ACE2
such
it
increased
emergence
risk.
Our
study
highlights
common
occurrence
their
implications
emergence.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: May 10, 2023
Abstract
The
ongoing
global
pandemic
of
coronavirus
disease
2019
(COVID-19),
caused
by
severe
acute
respiratory
syndrome
2
(SARS‐CoV‐2),
has
devastating
impacts
on
the
public
health
and
economy.
Rapid
viral
antigenic
evolution
led
to
continual
generation
new
variants.
Of
special
note
is
recently
expanding
Omicron
subvariants
that
are
capable
immune
evasion
from
most
existing
neutralizing
antibodies
(nAbs).
This
posed
challenges
for
prevention
treatment
COVID-19.
Therefore,
exploring
broad-spectrum
antiviral
agents
combat
emerging
variants
imperative.
In
sharp
contrast
massive
accumulation
mutations
within
SARS-CoV-2
receptor-binding
domain
(RBD),
S2
fusion
subunit
remained
highly
conserved
among
Hence,
S2-based
therapeutics
may
provide
effective
cross-protection
against
Here,
we
summarize
developed
inhibitors
(e.g.,
nAbs,
peptides,
proteins,
small-molecule
compounds)
candidate
vaccines
targeting
elements
in
subunit.
main
focus
includes
all
targetable
elements,
namely,
peptide,
stem
helix,
heptad
repeats
1
(HR1-HR2)
bundle.
Moreover,
a
detailed
summary
characteristics
action-mechanisms
each
class
cross-reactive
inhibitors,
which
should
guide
promote
future
design
coronaviruses.
Annual Review of Virology,
Journal Year:
2024,
Volume and Issue:
11(1), P. 21 - 42
Published: April 18, 2024
The
origin
of
SARS-CoV-2
has
evoked
heated
debate
and
strong
accusations,
yet
seemingly
little
resolution.
I
review
the
scientific
evidence
on
its
subsequent
spread
through
human
population.
available
data
clearly
point
to
a
natural
zoonotic
emergence
within,
or
closely
linked
to,
Huanan
Seafood
Wholesale
Market
in
Wuhan.
There
is
no
direct
linking
laboratory
work
conducted
at
Wuhan
Institute
Virology.
global
was
characterized
by
gradual
adaptation
humans,
with
dual
increases
transmissibility
virulence
until
Omicron
variant.
Of
note
been
frequent
transmission
from
humans
other
animals,
marking
it
as
strongly
host
generalist
virus.
Unless
lessons
are
learned,
inevitable
that
more
events
leading
epidemics
pandemics
will
plague
populations.